WebThe TruSight Oncology 500, TruSight Oncology 500 High-Throughput (HT), and TruSight Oncology 500 ctDNA workflows use a bead-based normalization (BBN) method to normalize library concentrations at the end of sample preparation. ... (TSO500) ctDNA input and reagents. Last modified 4d ago. Export as PDF. WebTo run TruSight Oncology 500 HT assay on the NovaSeq 6000 System, you’ll need a NovaSeq reagent kit. The choice of reagent kit depends on your throughput needs. ... TSO500 DNA/RNA HT Auto (72 spls) + Pierian 20049278. Price . Index Adapters. IDT® for Illumina® UMI DNA/RNA ...
"Enabling Scalable Comprehensive Genomic Profiling from FFPE …
WebJun 9, 2024 · Illumina’s TruSight Oncology 500 High-Throughput (TSO500 HT)assay enables labs to perform in-house CGP with scalability on a NovaSeq 6000 platform. In this CellPress webinar, Brian Piening of Providence Cancer Center will discuss why his team decided to implement in-house CGP and will share analytical performance data from their … WebTruSight Oncology ctDNA is a pan-cancer next-generation sequencing (NGS) assay that enables in-house comprehensive genomic profiling (CGP) from blood plasma. The broad panel is designed with similar DNA content as its tissue counterparts (TruSight Oncology 500 and TruSight Oncology 500 High-Throughput), including key immuno-oncology (IO ... browser least memory usage
TruSight Oncology 500 Documentation - Illumina, Inc.
WebProduct page and support links for TruSight Oncology 500 High Throughput (TSO500 HT) Product page and support links for TruSight Oncology 500 ctDNA. ... (TSO500 ctDNA) assesses multiple variant types in 523 cancer-related genes from cell-free DNA (cfDNA) obtained through liquid biopsies. WebTSO500_HT runs. He will also provide details of the center’s end-to-end workflow, including the data analysis flow and how they build their final reports. Learning Objectives • Providence Cancer Center’s implementation of in-house CGP • Illumina’s solution enabling in-house CGP Enabling scalable comprehensive genomic WebThe TruSight Oncology 500 test is a next-generation sequencing assay designed to cover over 500 genes associated with common solid tumors, including assessment of fusions, … evil genius rocket league